packageCerliponaseAlfa

cerliponase alfa

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Cerliponase alfa is an enzyme medication used to treat neuronal ceroid-lipofuscinosis, a rare metabolic disease. It is authorised in the European Union and is used only in specialised care for this very rare condition.

Summary written by glm-5.3-flash from Wikidata Q33626059 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:cerliponase alfa
ATC codes:A16AB17
DrugBank:DB13173
Wikidata:Q33626059
molar mass:59000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown